The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency

Journal of Heart and Lung Transplantation

Volumn 24, Issue 10, 2005, Pages 1517-1521

  Nathan, James A ^a   Sharples, Linda D ^a,b   Exley, Andrew R ^a   Sivasothy, Pasupathy ^a   Wallwork, John ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISOLONE;

ADULT; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNE DEFICIENCY; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BRONCHIECTASIS; CHEMOPREVENTION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 25844517660     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.11.013     Document Type: Article

References (25)

1. A. Hasan, P.A. Corris, M. Healy Bilateral sequential lung transplantation for end stage septic lung disease Thorax 50 1995 565 566
2. C.W. Barlow, R.C. Robbins, M.R. Moon, O. Akindipe, J. Theodore, B.A. Reitz Heart-lung verses double-lung transplantation for suppurative lung disease J Thorac Cardiovasc Surg 119 2000 466 476
3. S.C. Charman, L.D. Sharples, K.D. McNeil, J.D. Wallwork Assessment of survival benefit after lung transplantation by patient diagnosis J Heart Lung Transplant 21 2002 226 232
4. Joint statement of the American Society for Transplant Physicians, American Thoracic Society, European Respiratory Society, International Society for Heart and Lung Transplantation International guidelines for the selection of lung transplant candidates Am J Resp Crit Care Med 158 1998 335 339
5. M.L. Stanchina, K.G. Tantisira, S.L. Aquino, J.C. Wain, L.C. Ginns Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation J Heart Lung Transplant 21 2002 217 225
6. R.M. Aris, P.H. Gilligan, I.P. Neuringer, K.K. Gott, J. Rea, J.R. Yankaskas The effects of pan resistant bacteria in cystic fibrosis patients on lung transplant outcome Am J Respir Crit Care Med 155 1997 1699 1704
7. G.I. Snell, A. de Hoyos, M. Krajden, T. Winton, J.R. Maurer Pseudomonas capacia in lung transplant recipients with cystic fibrosis Chest 105 1994 310 312
8. T.M. Egan, F.C. Detterbeck, M.R. Mill Lung transplantation for cystic fibrosis effective and durable therapy in a high-risk group Ann Thorac Surg 66 2 1998 337 346
9. No authors listed Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies Clin Exp Immunol 118 Suppl 1 1999 1 28
10. M. Ballow Primary immunodeficiency disorders antibody deficiency J Allergy Clin Immunol 109 2002 581 591
11. M.C. Pasteur, S.M. Helliwell, S.J. Houghton An investigation into causative factors in patients with bronchiectasis Am J Resp Crit Care Med 162 2000 1277 1284
12. A.R. Exley, D. Bilton, A.M. Condliffe Antibody deficiency in adults with recurrent respiratory tract infections abstract Eur Respir J 18 Suppl 33 2001 106s
13. K.M. Thickett, D.S. Kumararatne, A.K. Banerjee, R. Dudley, D.E. Stableforth Common variable immune deficiency respiratory manifestations, pulmonary function and high-resolution CT scan findings QJM 95 2002 655 662
14. W.A. Sewell, M. Buckland, S.R. Jolles Therapeutic strategies in common variable immunodeficiency Drugs 63 2003 1359 1371
15. P.J. Busse, S. Razvi, C. Cunningham-Rundles Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency J Allergy Clin Immunol 109 2002 1001 1004
16. S. Kaveri, T. Vassilev, V. Hurez Antibodies to a conserved region of HLA class I molecules, capable of modulation CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use J Clin Invest 97 1996 865 869
17. J. Bayry, S. Lacroix-Desmazes, C. Carbonniel Inhibition of maturation and function of dendritic dells by intravenous immunoglobulin Blood 101 2003 758 765
18. A.T. Hill, R.A. Thompson, J. Wallwork, D.E. Stableforth Heart lung transplantation in a patient with end stage lung disease due to common variable immunodeficiency Thorax 53 1998 622 623
19. H. Griffiths, J. Lea, C. Bunch, M. Lee, H. Chapel Predictors of infection in chronic lymphocytic leukaemia Clin Exp Immunol 89 1992 374 377
20. M.H. Yamani, R. Avery, S. Mawhorter Hypogammaglobulinemia after heart transplantation impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes Transpl Infect Dis 3 Suppl 2 2001 40 43
21. N.S. Goldfarb, R.K. Avery, M. Goormastic Hypogammaglobulinemia in lung transplant recipients Transplantation 71 2001 242 246
22. P. Morales, D. Hernandez, R. Vicente Lung transplantation in patients with x-linked agammaglobulinemia Tranplant Proc 35 2003 1942 1943
23. H. Luckraz, L. Sharples, K. McNeil, T. Wreghitt, J. Wallwork Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation J Heart Lung Transplant 22 2003 287 291
24. H. Luckraz, M. Goddard, K. McNeil, C. Atkinson, S.C. Charman, S. Stewart Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation J Heart Lung Transplant 23 2004 527 531 2004
25. R.M. Kruger, S. Paranjothi, G.A. Storch, J.P. Lynch, E.P. Trulock Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients J Heart Lung Transplant 22 2003 754 763